GRACEcast
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
Visit Show Website http://cancerGRACE.org/Recently Aired
-
HD
Targeted Treatment for Lung Cancer After Progression
Dr. Geoffrey Oxnard of Dana-Farber Cancer Institute discusses whether or ...
Dr. Geoffrey Oxnard of Dana-Farber Cancer Institute discusses whether or not patients on targeted therapies, such as EGFR inhibitors, should stay on those therapies after their cancers begin to grow again. February 2014.
-
HD
Can Vaccines Fight Lung Cancer?
Dr. Charles Rudin of Memorial Sloan Kettering on the possibility ...
Dr. Charles Rudin of Memorial Sloan Kettering on the possibility of using vaccines to fight lung cancer. February 2014.
-
HD
CO-1686, a Third Generation Drug for EGFR Positive Lung Cancer Patients
Dr. Heather Wakelee of Stanford University Medical Center talks about ...
Dr. Heather Wakelee of Stanford University Medical Center talks about a drug still in development for EGFR lung cancer patients, CO-1686. February 2014.
-
HD
Why Do We Call Them "Small Cell Lung Cancer" and "Non-Small Cell Lung Cancer"?
Dr. Cathy Pietanza of Memorial Sloan Kettering explains how small ...
Dr. Cathy Pietanza of Memorial Sloan Kettering explains how small cell lung cancer and non-small cell lung cancer are differentiated. February 2014.
-
HD
Targeting the RAF Pathway in Lung Cancer
Dr. Charles Rudin of Memorial Sloan Kettering talks about RAF ...
Dr. Charles Rudin of Memorial Sloan Kettering talks about RAF and other genetic mutations that play a role in the growth of lung cancer. February 2014.
-
HD
Is It Possible to Test Lung Tumors Without Doing a Biopsy?
Dr. Geoffrey Oxnard of Dana-Farber Cancer Institute talks about exciting ...
Dr. Geoffrey Oxnard of Dana-Farber Cancer Institute talks about exciting new developments which will allow oncologists to test patients' lung tumors without invasive biopsies. February 2014.
-
HD
What Are PARP Inhibitors, and Might They Improve Outcomes in Small Cell Lung Cancer?
Dr. Charles Rudin of Memorial Sloan Kettering on how PARP ...
Dr. Charles Rudin of Memorial Sloan Kettering on how PARP inhibitors may benefit patients with small cell lung cancer. February 2014.
-
HD
New Insights into Small Cell Lung Cancer
Dr. Cathy Pietanza of Memorial Sloan Kettering on the new ...
Dr. Cathy Pietanza of Memorial Sloan Kettering on the new avenues of research into the treatment of small cell lung cancer. February 2014.
-
HD
In What Clinical Setting Should Immunotherapies Be Developed?
Dr. Charles Rudin of Memorial Sloan Kettering discusses immune therapies ...
Dr. Charles Rudin of Memorial Sloan Kettering discusses immune therapies that show promise in fighting lung cancer. February 2014.
-
HD
Maintenance Therapy in Small Cell Lung Cancer
Dr. Cathy Pietanza of Memorial Sloan Kettering on current and ...
Dr. Cathy Pietanza of Memorial Sloan Kettering on current and emerging treatments that are given to help keep small cell lung cancer from coming back after it has disappeared following initial therapy. February 2014.
